Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.3B | 4.3B | 4.4B | 4.3B |
Cost of revenue | 3.2B | 3.0B | 3.0B | 2.9B |
Gross profit | 1.1B | 1.2B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 373.5M | 395.0M | 331.5M | 320.0M |
Operating income | 557.4M | 1.0B | 1.1B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 529.5M | 509.8M | 521.1M | 507.0M |
Other income expense | — | — | — | — |
Pretax income | 61.4M | 558.0M | 609.8M | 691.1M |
Tax provision | 20.5M | 119.3M | 153.8M | 158.6M |
Net income | 40.9M | 438.7M | 456.1M | 532.5M |
Basic EPS | — | 4.2 | 4.3 | 5.1 |
Diluted EPS | — | 4.2 | 4.3 | 5.1 |
Basic average shares | — | 104.7M | 104.6M | 104.8M |
Diluted average shares | — | 104.7M | 104.6M | 104.8M |
EBITDA | 673.4M | 1.1B | 1.2B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -3.6M | -2.1M | -3.0M | -2.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |